21 CFR Part 11 supported, high-throughput workflows for regulated pharmaceutical labs, with next gen SIFT-MS

18 Sept 2024

Direct, real-time mass spectrometry offers regulated pharmaceutical and CDMO testing laboratories the opportunity to significantly reduce their time to analytical results due to minimal sample preparation, rapid sample analysis, and the inherent flexibility of column-free techniques. Comprised of the next-gen SIFT-MS Syft Tracer platform, integrated CTC autosampler, high-throughput inlet, and the SyftAuditTracer software package, the Syft Tracer Pharm11 is an analytical solution designed specifically for the pharmaceutical industry. Syft Technologies examines how the Syft Tracer Pharm11 is compliant with 21 CFR Part 11 by demonstrating an analytical workflow in which key regulatory compliance features are highlighted.

Syft Tracer Pharm11

Syft Technologies

Syft Tracer Pharm11 redefines genotoxic impurities analysis for compliant pharma and CDMO workflows as fast and easy with no sample preparation. This solution includes next-gen SIFT-MS Syft Tracer, a CTC autosampler, a high-throughput (HTP) inlet, and 21 CFR Part 11 compliant software SyftAuditTracer.

(0)

Links

Tags

21 CFR Part 11 supported, high-throughput workflows for regulated pharmaceutical labs, with next gen SIFT-MS